DK1913957T3 - Genetiske adjuvant-vacciner - Google Patents

Genetiske adjuvant-vacciner

Info

Publication number
DK1913957T3
DK1913957T3 DK07015414.1T DK07015414T DK1913957T3 DK 1913957 T3 DK1913957 T3 DK 1913957T3 DK 07015414 T DK07015414 T DK 07015414T DK 1913957 T3 DK1913957 T3 DK 1913957T3
Authority
DK
Denmark
Prior art keywords
genetic adjuvant
adjuvant vaccines
vaccines
genetic
inducing
Prior art date
Application number
DK07015414.1T
Other languages
English (en)
Inventor
Joel R Haynes
Georg Widera
James T Fuller
Timothy Shipley
Deborah Fuller
Mary Wu
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Priority claimed from EP99956885A external-priority patent/EP1227840B1/en
Application granted granted Critical
Publication of DK1913957T3 publication Critical patent/DK1913957T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK07015414.1T 1999-11-03 1999-11-03 Genetiske adjuvant-vacciner DK1913957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07015414A EP1913957B1 (en) 1999-11-03 1999-11-03 Adjuvanted genetic vaccines
EP99956885A EP1227840B1 (en) 1999-11-03 1999-11-03 Adjuvanted genetic vaccines

Publications (1)

Publication Number Publication Date
DK1913957T3 true DK1913957T3 (da) 2010-05-10

Family

ID=38763704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07015414.1T DK1913957T3 (da) 1999-11-03 1999-11-03 Genetiske adjuvant-vacciner

Country Status (5)

Country Link
EP (1) EP1913957B1 (da)
AT (1) ATE460945T1 (da)
DE (1) DE69942161D1 (da)
DK (1) DK1913957T3 (da)
SI (1) SI1227840T1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569348B (zh) * 2019-09-29 2023-02-28 中国食品药品检定研究院 一种带状疱疹疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9505691A (pt) * 1994-01-21 1996-01-16 Agracetus Instrumento para transporte de gente acionado por gás
WO1998046263A1 (en) * 1997-04-14 1998-10-22 University Of Massachusetts Medical Center Saponin adjuvants in combination with dna vaccination
HUP0101139A3 (en) * 1997-12-02 2003-11-28 Powderject Vaccines Inc Madiso Transdermal delivery of particulate vaccine compositions
GB9818627D0 (en) * 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
ATE374622T1 (de) * 1999-11-03 2007-10-15 Powderject Vaccines Inc Genetische impstoffe mit adjuvans

Also Published As

Publication number Publication date
EP1913957A1 (en) 2008-04-23
DE69942161D1 (de) 2010-04-29
SI1227840T1 (sl) 2008-02-29
ATE460945T1 (de) 2010-04-15
EP1913957B1 (en) 2010-03-17

Similar Documents

Publication Publication Date Title
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
DE69929444D1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
ATE406912T1 (de) Immunisierung gegen chlamydia tracheomatis
DK1047784T3 (da) Neissera meningitidis-antigener
ATE350394T1 (de) Gonokokkenproteine und nukleinsäuren
WO2003059381A3 (en) Immunogenic preparations and vaccines on the basis of mrna
CY1112749T1 (el) Εμβολια διεγερσης/αναμνησης κατα της ελονοσιας
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
DK1147117T3 (da) Immunologiske adjuvansforbindelser
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
DE60144201D1 (de) Lawsonia intracellularis Impfstoff
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
DE69828182D1 (de) Polynukleotid-impfstoff-formulierungen
DK1913957T3 (da) Genetiske adjuvant-vacciner
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
NO20041564L (no) Infeksios lakse anemi-virus vaksine
DK1490100T3 (da) Kombinerede DNA/proteinvaccinepræparater
DK1176192T3 (da) Helicobacter felis-vaccine